The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression-The Results From the KEOpS Study
- PMID: 33041803
- PMCID: PMC7522396
- DOI: 10.3389/fphar.2020.562137
The Combination of Propofol and Ketamine Does Not Enhance Clinical Responses to Electroconvulsive Therapy in Major Depression-The Results From the KEOpS Study
Abstract
Objective: We investigated the clinical effects of the combination of ketamine and propofol as anesthetic agents during electroconvulsive therapy (ECT) in patients with uni- or bipolar major depressive episodes. We hypothesized that ketamine may confer short- and long- term advantages in improving depressive symptoms at the early stages of ECT.
Methods: In a randomized placebo-controlled trial, remission rates after 4 and 8 weeks of ECT were compared between patients who were randomly allocated to receive either the combination of ketamine (0.5 mg/kg) + propofol (n= 11) or placebo + propofol (n = 16). Depressive symptoms were assessed weekly using the Montgomery-Åsberg Depression Rating Scale (MADRS); ECT sessions were administered twice per week for a maximum of 8 weeks (16 sessions).
Results: After 4 weeks, we observed significantly fewer remitters (MADRS score < 10) in the ketamine + propofol group (0/11; 0%) than in the placebo + propofol group (5/16; 31%; χ2 = 4.22; p = 0.040). No significant difference was observed between the two groups regarding the number of patients who achieved remission weekly throughout the study period (Chi² = 3.588; p = 0.058). The mean duration of seizures was significantly shorter in the ketamine + propofol group than in the placebo + propofol group.
Conclusions: The results from the current study corroborated results from previously published studies and did not support the use of the combination of ketamine + propofol as an anesthetic agent for ECT in patients with major depressive episodes in clinical settings.
Keywords: bipolar; electroconvulsive therapy; ketamine; major depressive episode; propofol.
Copyright © 2020 Brunelin, Iceta, Plaze, Gaillard, Simon, Suaud-Chagny, Galvao and Poulet.
Figures
Similar articles
-
A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression.J Affect Disord. 2018 Feb;227:372-378. doi: 10.1016/j.jad.2017.11.034. Epub 2017 Nov 10. J Affect Disord. 2018. PMID: 29149755 Clinical Trial.
-
Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy: a randomized controlled trial.Braz J Psychiatry. 2022 Jan-Feb;44(1):6-14. doi: 10.1590/1516-4446-2020-1705. Braz J Psychiatry. 2022. PMID: 34076068 Free PMC article. Clinical Trial.
-
Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled study.Can J Anaesth. 2018 Jun;65(6):636-646. doi: 10.1007/s12630-018-1088-0. Epub 2018 Feb 21. Can J Anaesth. 2018. PMID: 29700801 Clinical Trial. English.
-
Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: A meta-analysis of randomized controlled trials.J Affect Disord. 2019 May 1;250:123-131. doi: 10.1016/j.jad.2019.02.044. Epub 2019 Feb 18. J Affect Disord. 2019. PMID: 30852364
-
A review of ketamine's role in ECT and non-ECT settings.Neuropsychiatr Dis Treat. 2018 Jun 6;14:1437-1450. doi: 10.2147/NDT.S157233. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29922060 Free PMC article. Review.
Cited by
-
Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression.Brain Sci. 2022 Jan 18;12(2):126. doi: 10.3390/brainsci12020126. Brain Sci. 2022. PMID: 35203890 Free PMC article.
-
Dexmedetomidine vs Propofol as an Adjunct to Ketamine for Electroconvulsive Therapy Anaesthesia.Turk J Anaesthesiol Reanim. 2022 Apr;50(2):114-120. doi: 10.5152/TJAR.2021.21217. Turk J Anaesthesiol Reanim. 2022. PMID: 35544250 Free PMC article.
References
-
- Anderson I. M., Blamire A., Branton T., Clark R., Downey D., Dunn G., et al. (2017). Ketamine-ECT Study team. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial. Lancet Psychiatry 4 (5), 365–377. 10.1016/S2215-0366(17)30077-9 - DOI - PMC - PubMed
-
- Asztalos M., Matzen P., Licht R. W., Hessellund K. B., Sartorius A., Nielsen R. E. (2018). Delaying initiation of electroconvulsive treatment after administration of the anaesthetic agent and muscle relaxant reduces the necessity of re-stimulation. Nord. J. Psychiatry 72 (5), 341–346. 10.1080/08039488.2018.1459833 - DOI - PubMed
LinkOut - more resources
Full Text Sources